Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,447 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and tolerability of nanoparticle albumin-bound paclitaxel in combination with carboplatin as a late-phase chemotherapy for recurrent and advanced non-small-cell lung cancer: A multi-center study of the Fukushima lung cancer association group of surgeons.
Higuchi M, Takagi H, Owada Y, Inoue T, Watanabe Y, Yamaura T, Fukuhara M, Muto S, Okabe N, Matsumura Y, Hasegawa T, Yonechi A, Osugi J, Hoshino M, Shio Y, Fujiu K, Kanno R, Ohishi A, Suzuki H, Gotoh M. Higuchi M, et al. Among authors: hoshino m. Oncol Lett. 2017 Jun;13(6):4315-4321. doi: 10.3892/ol.2017.5998. Epub 2017 Apr 5. Oncol Lett. 2017. PMID: 28599432 Free PMC article.
Phase I trial of preoperative intratumoral injection of immature dendritic cells and OK-432 for resectable pancreatic cancer patients.
Endo H, Saito T, Kenjo A, Hoshino M, Terashima M, Sato T, Anazawa T, Kimura T, Tsuchiya T, Irisawa A, Ohira H, Hikichi T, Takagi T, Gotoh M. Endo H, et al. Among authors: hoshino m. J Hepatobiliary Pancreat Sci. 2012 Jul;19(4):465-75. doi: 10.1007/s00534-011-0457-7. J Hepatobiliary Pancreat Sci. 2012. PMID: 21983893 Clinical Trial.
Multiple therapeutic peptide vaccines consisting of combined novel cancer testis antigens and anti-angiogenic peptides for patients with non-small cell lung cancer.
Suzuki H, Fukuhara M, Yamaura T, Mutoh S, Okabe N, Yaginuma H, Hasegawa T, Yonechi A, Osugi J, Hoshino M, Kimura T, Higuchi M, Shio Y, Ise K, Takeda K, Gotoh M. Suzuki H, et al. Among authors: hoshino m. J Transl Med. 2013 Apr 11;11:97. doi: 10.1186/1479-5876-11-97. J Transl Med. 2013. PMID: 23578144 Free PMC article. Clinical Trial.
Recent advances in immunotherapy for non-small-cell lung cancer.
Suzuki H, Owada Y, Watanabe Y, Inoue T, Fukuharav M, Yamaura T, Mutoh S, Okabe N, Yaginuma H, Hasegawa T, Yonechi A, Ohsugi J, Hoshino M, Higuchi M, Shio Y, Gotoh M. Suzuki H, et al. Among authors: hoshino m. Hum Vaccin Immunother. 2014;10(2):352-7. doi: 10.4161/hv.26919. Epub 2013 Nov 6. Hum Vaccin Immunother. 2014. PMID: 24196313 Free PMC article. Review.
Prognostic Impact of Hypoxia-Inducible miRNA-210 in Patients with Lung Adenocarcinoma.
Osugi J, Kimura Y, Owada Y, Inoue T, Watanabe Y, Yamaura T, Fukuhara M, Muto S, Okabe N, Matsumura Y, Hasegawa T, Yonechi A, Hoshino M, Higuchi M, Shio Y, Suzuki H, Gotoh M. Osugi J, et al. Among authors: hoshino m. J Oncol. 2015;2015:316745. doi: 10.1155/2015/316745. Epub 2015 Feb 5. J Oncol. 2015. PMID: 25733977 Free PMC article.
1,447 results